About 10% to 15% of women experience clinically significant depressive symptoms during pregnancy. Furthermore, women with a history of major depression appear to be at high risk for recurrent illness during pregnancy particularly in the [...]
2014 was a huge year in the field of Reproductive Psychiatry. Never before have we seen so many articles published in this specialty. Much attention has focused on the reproductive safety of psychotropic medication; however, we have seen an increased interest in the mental health of women and a greater appreciation of how psychiatric illness in the mother may affect the entire family, including her unborn child and family.
A recent study examined the prevalence and risk factors for perinatal depression and anxiety in a group of Norwegian women with epilepsy (n = 706) compared to pregnancies in all women without epilepsy (n = 106,511).
85 women with postpartum depression were randomized to receive acupuncture plus psychological intervention (five sessions per week) or treatment with fluoxetine (20 mg per day). The two groups were treated continuously for six weeks. Depressive symptoms were measured using the Hamilton Depression scale (HAMD).
Some, but not all, studies have demonstrated an increased risk of miscarriage among women who take antidepressants. However, it has been difficult to determine whether this increased risk was related to exposure to the medication [...]
We have received many emails and calls from colleagues and patients regarding the recent article on the safety of SSRI use during pregnancy published in the New York Times. In this article, health writer Roni Caryn Rabin, detailed the risks associated with the use of antidepressants during pregnancy.
SSRIs were not associated with an increased risk of miscarriage.
This is from Katherine Stone at Postpartum Progress. Katherine Stone has long been an advocate for women with perinatal mood and anxiety disorders. In addition to her website which provides information and support, she has [...]
As many as 30% of people suffering from depression do not respond to antidepressant treatment1. When treatment options are exhausted psychiatrists often turn to electroconvulsive therapy (ECT). An electric current is used to cause a brief seizure in the brain. Although this is a relatively safe method of treatment, impairments of both cognition and memory are potential side effects2.
Most studies evaluating the prevalence of perinatal depression are cross-sectional, meaning that depressive symptoms are measured at a single point in time. Less information is available regarding the trajectory of perinatal depression. In obstetric populations, it seems that there are women with briefer episodes of milder postpartum depressive symptoms, while others have more persistent and debilitating depressive symptoms after childbirth. Other women experience depression during pregnancy. Several studies suggest that there is considerable heterogeneity among women who experience depressive symptoms during pregnancy and the postpartum period.
